Related Experiment Videos
[Cutaneous achromia and malignant melanoma]
Annales De Dermatologie Et De Venereologie
|January 1, 1984
Summary
Cutaneous depigmentation, including vitiligo, was observed in 29 of 500 malignant melanoma cases. This phenomenon, particularly post-excision vitiligo, may not indicate a significant prognostic factor in human melanoma.
Area of Science:
- Dermatology
- Oncology
- Pathology
Context:
- Malignant melanoma can present with or be associated with cutaneous depigmentation.
- Depigmentation phenomena, such as vitiligo, halo-naevus, and localized achromia, have been noted in relation to melanoma.
- These depigmentation patterns are well-documented in animal pathology, often as a favorable prognostic indicator.
Purpose:
- To investigate the occurrence and characteristics of cutaneous depigmentation associated with malignant melanoma in a human cohort.
- To compare the observed depigmentation patterns with those reported in animal models.
- To evaluate the potential prognostic significance of these depigmentations in malignant melanoma.
Summary:
- Cutaneous depigmentation was observed in 29 out of 500 malignant melanoma patients.
- Depigmentation occurred around the primary tumor, excision scar, or at sites of immunological testing (BCG, DNCB).
- While depigmentation is a good prognostic factor in animals, this study found no clear prognostic significance in human malignant melanoma.
Impact:
- Highlights the association between depigmentation and malignant melanoma.
- Suggests that depigmentation phenomena in human melanoma may not share the same prognostic implications as observed in animal studies.
- Contributes to understanding the complex relationship between melanoma and immune-related skin changes.